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Since the 1990s, reports of Q fever in Nova Scotia, 
Canada, have declined. Passive surveillance for Q fever in 
Nova Scotia and its neighboring provinces in eastern Cana-
da indicates that the clinical manifestation of Q fever in the 
Maritime provinces is pneumonia and that incidence of the 
disease may ﬂ  uctuate.
T
he ﬁ  rst cases of Q fever in Nova Scotia were recognized 
in 1979 during a study of atypical pneumonia (1). This 
observation led to a series of studies that showed that Q 
fever was common in Nova Scotia (50–60 cases per year in 
a population of ≈950,000) and that the epidemiology was 
unique; exposure to infected parturient cats or newborn kit-
tens was the major risk factor for infection (2). At about the 
same time, cat-related outbreaks were noted in neighboring 
Prince Edward Island and New Brunswick (2). In the early 
1990s, cases began to decline; but, to our knowledge, since 
1999 Q fever in this area has not been systematically stud-
ied. We undertook the current study to determine whether 
Q fever was still occurring in Maritime Canada (the 3 prov-
inces of New Brunswick, Nova Scotia, and Prince Edward 
Island in eastern Canada) and whether the decline in cases 
was real or an artifact of decreased surveillance.
The Study
The study began in December 2004 and terminated on 
February 17, 2007. A notice sent to all physicians in Mari-
time Canada described the study and asked the physicians 
to submit serum samples from patients with suspected Q 
fever (febrile illness or pneumonia after exposure to par-
turient cats or other animals; outbreaks of pneumonia in 
a family). All samples were sent to the Nova Scotia Pub-
lic Health Laboratory for testing for antibodies to Coxiella 
burnetii. Physicians of patients with a positive test result 
were contacted, and they in turn contacted their patients to 
ask if they would participate in the study. This study was 
approved by the University of Alberta Research Ethics Re-
view Board and the Capital Health Research Ethics Board.
During the study period, serum samples from 210 pa-
tients suspected of having C. burnetii infection were tested 
by using commercially available immunoglobulin (Ig) M 
and IgG ELISAs (PanBio, Brisbane, Queensland, Austra-
lia). Patients with positive IgM ELISA results were asked 
to participate in the study. Convalescent-phase samples 
were collected from those who agreed; further testing for 
IgG antibodies to phase I and phase II C. burnetii antigen 
was conducted by using an indirect immunoﬂ  uorescence 
test as previously described (3).
Of the 210 patients, 35 had antibodies to C. burnetii 
and 13 met the criteria for acute Q fever (positive IgM 
ELISA result and a >4-fold rise in antibody to phase II an-
tigen between the acute- and convalescent-phase samples). 
Phase I titers >512, suggestive of chronic Q fever, were 
found for 3 patients. The other 19 patients had serologic 
proﬁ  les suggestive of previous exposure to C. burnetii. Of 
the 13 patients who ﬁ  t the case deﬁ  nition of acute infec-
tion, 11 agreed to participate in the study, 1 declined, and 1 
moved to another country.
Of the 11 participating patients, 7 were from Nova 
Scotia, 2 were from New Brunswick, and 2 were from 
Prince Edward Island; 6 were male; and mean age was 54.6 
years (Table). One case occurred in December 2004; 6 in 
2005; 4 in 2006, and no cases in the ﬁ  rst 6 weeks of 2007. 
Cases occurred in every month except August, September, 
October, and February. 
All patients except patient 6 had risk factors for Q fe-
ver (Table). One patient (patient 8) was a sheep farmer who 
had recently had ≈60 lambs born on his farm, several of 
which were stillborn in the 2 weeks before the farmer be-
came ill; 7 patients had >1 cat as a pet; and only 2 (patients 
5 and 8) had no pets. 
In terms of clinical signs, all 11 patients had sweats, fe-
ver, and myalgia; 9 had chills; 8 had a cough; 7 were short 
of breath; 5 each had nausea, diarrhea, sputum production, 
and confusion; 4 had chest pain, which was pleuritic for 2; 
and 2 had abdominal pain and vomiting. Of the 7 patients 
for whom chest radiographs were taken, 6 had acute opaci-
ties compatible with pneumonia. Patient 11 had diffuse bi-
lateral pneumonia, which required him to be admitted to an 
intensive care unit to receive ventilatory support (Figure).
All 11 patients recovered. Only 4 received initial em-
piric therapy that would be considered effective against C. 
burnetii, e.g., doxycycline (n = 2), ciproﬂ  oxacin (n = 1), or 
levoﬂ  oxacin (n = 1). Four other patients received azithro-
mycin, which may have been effective but has suboptimal 
in vitro activity against C. burnetii (4).
Conclusions
Acute Q fever is still present in Maritime Canada; 
however, the number of cases has diminished considerably 
from the 1980s and early 1990s. Since 2004, only 4–5 cases 
have been reported each year. The passive design of our 
study may have underestimated the number of cases. How-
ever, in the 1980s, a number of Q fever outbreaks involved 
entire families. A typical scenario was exposure to the 
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everyone in the family became ill (2). Some outbreaks in-
volved poker players (5) or most of the employees of a fac-
tory (6). For our study, we carefully asked whether family 
members were ill; only 2 patients mentioned such illness, 
and for each, it was a spouse.
Pneumonia seems to still be the dominant form of 
acute Q fever in Maritime Canada. Of the 7 patients for 
whom chest radiographs were taken, 6 had pneumonia. 
Major differences in the manifestations of Q fever occur in 
different regions. In Maritime Canada and in the Basque re-
gion of Spain, the predominant manifestation is pneumonia 
(7,8); in Newfoundland and Australia, fever with no appar-
ent localization of infection (9,10); in the Canary Islands, 
fever and hepatitis; and in southern France, hepatitis and 
pneumonia, although hepatitis is more frequent than pneu-
monia (11,12). The factors responsible for these disparate 
manifestations are not known. When isolates of C. burnetii 
from different geographic areas were typed by using multi-
sequence typing, all 7 isolates from Nova Scotia were iden-
tical and shared this type with 2 isolates from France and 1 
from the United States (13).
The reservoirs for human infection with C. burnetii in 
Nova Scotia have likely spread from cats and dogs (14) 
to the more traditional reservoirs of sheep and cattle (12). 
Patient 8, a sheep farmer, had pneumonia that appeared on 
radiographs as a rounded opacity in the right middle lobe. 
Rounded opacities are very common in cat-associated cases 
of Q fever but may not be speciﬁ  c for cat-associated infec-
tion (15).
Our ﬁ  ndings indicate that after C. burnetii is estab-
lished in an area, it is likely to persist, although the inci-
dence may ﬂ  uctuate. Clinical manifestations, which in our 
study were limited to pneumonia, remain stable.
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‡Required intubation. 
Figure. Chest radiograph of patient 11 at time of admission to 
hospital, before intubation, demonstrating extensive bilateral 
airspace disease.Q Fever Update, Maritime Canada
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